Back To Schedule
Tuesday, June 26 • 2:00pm - 3:15pm
#253: Digitizing a Patient-Focused Clinical Trial Experience

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-589-L04-P; CME 1.25; IACET 1.25; RN 1.25

During this interactive session, leaders from TransCelerate Member Companies will candidly share their experiences collaborating to create solutions that will bring about innovative change, and address some of our industry’s greatest challenges.

Learning Objectives

Discuss the four key initiatives that, using innovative digital efforts, has to potential to transform clinical trials; Recognize how the use of patient technologies, eConsent, eLabels, and electronic health records can advance clinical research.


Kelley Erb, PhD


Stephen Yates, PhD

Wayne R. Kubick, MBA

T.J. Sharpe, PMP

avatar for Kelley Erb

Kelley Erb

Lead for TransCelerate’s Novel Digital Endpoints; Director, Digital Medicine, Pfizer Inc
At Pfizer, Kelley serves as project leader for multiple digital medicine programs aimed at developing, validating, and implementing novel digital endpoints for asset teams across the portfolio. At TransCelerate, he leads the novel digital endpoints team focused on delivering pre-competitive... Read More →
avatar for Wayne Kubick

Wayne Kubick

Chief Technology Officer, HL7 International
Mr. Kubick is CTO for Health Level Seven International, intent on improving clinical research through technology and data standards. He was formerly CTO and a Board member for CDISC, and has 2+ decades in a variety of leadership roles in clinical R&D with BBN, Parexel International... Read More →
avatar for T.J. Sharpe

T.J. Sharpe

Patient Advocate, Starfish Harbor LLC
T.J. Sharpe is a Stage IV melanoma patient who shares his journey through cancer in his Patient #1 Blog.  He was diagnosed in August 2012 with metastatic melanoma, weeks after his second child was born. He has undergone six surgeries and four immunotherapy treatments over two different... Read More →
avatar for Stephen Yates

Stephen Yates

Clinical Program Director, UCB Bioscience, Inc.
Stephen Yates a Clin Prog Dir and Head, Pt Engagement Strategy with UCB Biosciences, Inc. He provides strategy for Ph2 through 4 clinical studies focused in neurology and metabolic disease. Stephen also provides oversight of UCB’s strategy for patient engagement throughout the development... Read More →

Tuesday June 26, 2018 2:00pm - 3:15pm EDT
Room 258AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  02: ClinTrials -ClinOps, Forum